Possibilities of Bone Scintigraphy and Additional Radionuclide Techniques in the Diagnosis and Treatment of Patients with Osteogenic Sarcoma
A. D. Ryzhkov,
A. S. Krylov,
G. N. Machak,
A. I. Pronin,
T. M. Geliashvili,
E. A. Nikolaeva,
A. V. Pavlova https://doi.org/10.37174/2587-7593-2023-6-2-20-33
Abstract
This review, using illustrative examples, shows the possibilities of using bone scintigraphy as a basic method for examining patients with osteosarcoma in accordance with the most significant international and domestic recommendations. The material is based on many years of experience and our own database of more than 1000 observations. The possibilities of other radionuclide diagnostic techniques in the diagnosis and monitoring of patients with osteosarcoma in solving various clinical problems are shown. The expediency of using three-phase osteoscitigraphy is based on the examination of 95 patients in dynamics. Radionuclide diagnostics has not lost its importance in the diagnosis of osteosarcoma and its metastases and continues to be in demand among pediatric and adult oncologists.
About the Authors
A. D. Ryzhkov
N.N. Blokhin National Medical Research Center of Oncology; Russian Medical Academy of Continuous Professional Education
Russian Federation
Russian Federation
24, Kashirskoye Shosse, Moscow, 115478; 2/1, build. 1, Barricadnaya str., Moscow, 125993
A. S. Krylov
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Russian Federation
24, Kashirskoye Shosse, Moscow, 115478
G. N. Machak
N.N. Priorov National Medical Research Center for Traumatology and Orthopedics
Russian Federation
Russian Federation
10, Priorova str., Moscow, 127299
A. I. Pronin
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Russian Federation
24, Kashirskoye Shosse, Moscow, 115478
T. M. Geliashvili
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Russian Federation
24, Kashirskoye Shosse, Moscow, 115478
E. A. Nikolaeva
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Russian Federation
24, Kashirskoye Shosse, Moscow, 115478
A. V. Pavlova
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Russian Federation
24, Kashirskoye Shosse, Moscow, 115478
References
1. Nemec SF, Krestan CR, Hojreh A, Hƺrmann M. Radiologische Diagnostik maligner Tumoren des Muskuloskelettalsystems im Kindes- und Adoleszentenalter [Radiological diagnostics of malignant tumors of the musculoskeletal system in childhood and adolescence]. Radiologe. 2008 Oct;48(10):962-8. (In German). DOI: 10.1007/s00117-008-1651-8.
2. Wittig JC, Bickels J, Priebat D, et al. Osteosarcoma: a multidisciplinary approach to diagnosis and treatment. Am Fam Physician. 2002 Mar 15;65(6):1123-32. PMID: 11925089.
3. Chew FS, Hudson TM. Radionuclide bone scanning of osteosarcoma: falsely extended uptake patterns. AJR Am J Roentgenol. 1982 Jul;139(1):49-54. DOI: 10.2214/ ajr.139.1.49.
4. Goldstein H, McNeil BJ, Zufall E, et al. Changing indications for bone scintigraphy in patients with osteosarcoma. Radiology. 1980 Apr;135(1):177-80. DOI: 10.1148/radiology.
5. Забродина АВ, Рыжков АД. Сравнительный анализ результатов радионуклидного исследования и традиционной рентгенографии у больных с остеогенной саркомой. Вестник ОНЦ РАМН. 1996;4:27-33. [Zabrodina AV, Ryzhkov AD. Comparative analysis of the results of radionuclide study and traditional radiography in patients with osteogenic sarcoma. Bulletin of ONTS RAMS. 1996;4:27-33 (In Russian)].
6. Powers JM, Cost C, Cederberg K, et al. Bone scintigraphy in osteosarcoma: a single institution experience. J Pediatr Hematol Oncol. 2014 Nov;36(8):e543-5. DOI: 10.1097/ MPH.0000000000000182.
7. Subramanian G, McAfee JG, Blair RJ, et al. Technetium-99m-methylene diphosphonate -- a superior agent for skeletal imaging: comparison with other technetium complexes. J Nucl Med. 1975 Aug;16(8):744-55. PMID: 170385.
8. Rieden K, Adolph J, Mende U, Georgi P. Radiologische Diagnostik von Knochenmetastasen [Radiologic diagnosis of bone metastases]. Rontgenblatter. 1989 Feb;42(2):95- 103. (In German). PMID: 2648554.
9. Ozarda AT, Legaspi JR, Haynie TP. Detection of a brain metastasis from osteosarcoma with 99mTc-methylene diphosphonate bone scanning. Eur J Nucl Med. 1983;8(12):552-4. DOI: 10.1007/BF00251620.
10. Brown KT, Kattapuram SV, Rosenthal DI. Computed tomography analysis of bone tumors: patterns of cortical destruction and soft tissue extension. Skeletal Radiol. 1986;15(6):448-51. DOI: 10.1007/BF00355103.
11. Kenney PJ, Gilula LA, Murphy WA. The use of computed tomography to distinguish osteochondroma and chondrosarcoma. Radiology. 1981 Apr;139(1):129-37. DOI: 10.1148/ radiology.139.1.6937887.
12. Aisen AM, Martel W, Braunstein EM, et al. MRI and CT evaluation of primary bone and soչ-tissue tumors. AJR Am J Roentgenol. 1986 Apr;146(4):749-56. DOI: 10.2214/ ajr.146.4.749.
13. Rubin DA. Magnetic resonance imaging: Practical considerations. In: Resnick D, Kransdorf MJ, editors. Bone and joint imaging. 3rd ed. Philadelphia Pennsylvania: Elsevier Saunders; 2005:118-32.
14. Bohndorf K, Reiser M, Lochner B, et al. Magnetic resonance imaging of primary tumours and tumour-like lesions of bone. Skeletal Radiol. 1986;15(7):511-7. DOI: 10.1007/BF00361046.
15. Inarejos Clemente EJ, Navarro OM, Navallas M, et al. Multiparametric MRI evaluation of bone sarcomas in children. Insights Imaging. 2022 Mar 1;13(1):33. DOI: 10.1186/s13244-022-01177-9.
16. Arndt CA, Rose PS, Folpe AL, Laack NN. Common musculoskeletal tumors of childhood and adolescence. Mayo Clin Proc. 2012 May;87(5):475-87. DOI: 10.1016/j.mayocp.2012.01.015.
17. Ryzhkov AD, Gabunia RI, Korzhenkova GP, et al. The use of single photon emission tomography in the diagnosis of lesions in osteogenic sarcoma. Medical Radiology and Radiation Safety, 1997;4:31- 4. (In Russian).
18. Pevarski DJ, Drane WE, Scarborough MT. The usefulness of bone scintigraphy with SPECT images for detection of pulmonary metastases from osteosarcoma. AJR Am J Roentgenol. 1998 Feb;170(2):319-22. DOI: 10.2214/ ajr.170.2.9456937.
19. Clinical Guidelines for Bone Sarcomas. Adults. Russian Federation. 2022. (In Russian).
20. Van den Wyngaert T, Strobel K, Kampen WU, et al. EANM Bone & Joint Committee and the Oncology Committee. The EANM practice guidelines for bone scintigraphy. Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1723-38. DOI: 10.1007/s00259-016-3415-4.
21. Beheshti M, Mottaghy FM, Paycha F, et al. 18F-NaF PET/ CT: EANM procedure guidelines for bone imaging. Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1767-77. DOI: 10.1007/s00259-015-3138-y.
22. Im HJ, Kim TS, Park S!, et al. Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, aչer one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma. Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):39-49. DOI: 10.1007/s00259-011-1936-4.
23. Cistaro A, Lopci E, Gastaldo L, et al. The role of 18F-FDG PET/CT in the metabolic characterization of lung nodules in pediatric patients with bone sarcoma. Pediatr Blood Cancer. 2012 Dec 15;59(7):1206-10. DOI: 10.1002/ pbc.24242.
24. Strauss SJ, Frezza AM, Abecassis N, et al. ESMO Guidelines Committee, EURACAN, GENTURIS and ERN PaedCan. Electronic address: clinicalguidelines@ esmo.org. Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2021 Dec;32(12):1520-36. DOI: 10.1016/j.annonc.2021.08.1995.
25. Gold RH, Hawkins RA, Katz RD. Bacterial osteomyelitis: findings on plain radiography, CT, MR, and scintigraphy. AJR Am J Roentgenol. 1991 Aug;157(2):365-70. DOI: 10.2214/ajr.157.2.1853823.
26. Kwon HW, Paeng JC, Nahm FS, et al. Diagnostic performance of three-phase bone scan for complex regional pain syndrome type 1 with optimally modified image criteria. Nucl Med Mol Imaging. 2011 Dec;45(4):261-7. DOI: 10.1007/s13139-011-0104-x.
27. Kim JY, Choi YY, Kim CW, et al. Bone Scintigraphy in the Diagnosis of Rheumatoid Arthritis: Is There Additional Value of Bone Scintigraphy with Blood Pool Phase over Conventional Bone Scintigraphy? J Korean Med Sci. 2016 Apr;31(4):502-9. DOI: 10.3346/jkms.2016.31.4.502.
28. Love C, Tomas MB, Marwin SE, et al. Role of nuclear medicine in diagnosis of the infected joint replacement. Radiographics. 2001 Sep-Oct;21(5):1229-38. DOI: 10.1148/ radiographics.21.5.g01se191229.
29. Kumar K. Three phase bone scan interpretation based upon vascular endothelial response. Indian J Nucl Med. 2015 Apr-Jun;30(2):104-10. DOI: 10.4103/0972- 3919.152949.
30. Drane WE. Myositis ossificans and the three-phase bone scan. AJR Am J Roentgenol. 1984 Jan;142(1):179-80. DOI: 10.2214/ajr.142.1.179.
31. Ozcan Z, Burak Z, KumanlioƉlu K, et al. Assessment of chemotherapy-induced changes in bone sarcomas: clinical experience with 99mTc-MDP three-phase dynamic bone scintigraphy. Nucl Med Commun. 1999 Jan;20(1):41- 8. DOI: 10.1097/00006231-199901000-00008.
32. Machak GN, Tkachev SI, Solovyev !N, et al. Neoadjuvant chemotherapy and local radiotherapy for high-grade osteosarcoma of the extremities. Mayo Clin Proc. 2003 Feb;78(2):147-55. DOI: 10.4065/78.2.147.
33. Machak GN. Modern possibilities and prospects of combined treatment of osteosarcoma. Dissertation of Dr. Med. Sci. Moscow, 2007. (In Russian).
34. Bludov AB. The role of radiodiagnostic methods in evaluating the effectiveness of preoperative chemotherapy in patients with bone sarcomas. Dissertation of PhD Med. Sci. Moscow, 2013. (In Russian).
Review
For citations:
Ryzhkov A.D., Krylov A.S., Machak G.N., Pronin A.I., Geliashvili T.M., Nikolaeva E.A., Pavlova A.V. Possibilities of Bone Scintigraphy and Additional Radionuclide Techniques in the Diagnosis and Treatment of Patients with Osteogenic Sarcoma. Journal of oncology: diagnostic radiology and radiotherapy. 2023;6(2):20-33. (In Russ.) https://doi.org/10.37174/2587-7593-2023-6-2-20-33
Views:
301
Email this article 